Dr. Fred Hirsch Discusses Recent, Exciting Advancements in Lung Cancer Therapy
By Dr. Fred Hirsch - Last Updated: December 19, 2023There is no shortage of innovation happening in the world of lung cancer. Coming off such notable conferences as the 2023 World Conference on Lung Cancer, ESMO Congress 2023, and The 18th Annual New York Lung Cancers Symposium, Lung Cancers Today spoke with Fred R. Hirsch, MD, PhD, of Mount Sinai, about current and future lung cancer treatments and innovations that pique his interest.
Advertisement
Advertisement
Related Posts
Certain surgical procedures and margins were more frequent in patients who had suture-line recurrences.
The long-term follow-up data shows that PFS remains unreached in the subgroup of Asian patients in the CROWN study.
Researchers evaluated if there was a link between pretreatment systemic immune inflammation index levels and outcomes.
Study investigators say the combination "showed promising efficacy" in patients with relapsed small cell lung cancer.
Clinicians hypothesize that the genetic mutation, known as RUFY1-RET fusion, caused resistance to lorlatinib.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.